In vitro antioxidant activity of valeriana officinalis against different neurotoxic agents

Neurochemical Research

Volumn 34, Issue 8, 2009, Pages 1372-1379

  Sudati, Jéssie Haigert ^a   Fachinetto, Roselei ^a   Pereira, Romaiana Picada ^a   Boligon, Aline Augusti ^b   Athayde, Margareth Linde ^b   Soares, Felix Antunes ^a   De Vargas Barbosa, Nilda Berenice ^a   Rocha, João Batista Teixeira ^a  

^a Laboratorio de Sintese   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Deoxyribose degradation; Ethanolic extract; Oxidative stress; Pro oxidant agents; TBARS; Valeriana officinalis

Indexed keywords

3 NITROPROPIONIC ACID; DEOXYRIBOSE; FERROUS SULFATE; NEUROTOXIN; NITROPRUSSIDE SODIUM; QUINOLINIC ACID; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; VALERIAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN CORTEX; BRAIN HOMOGENATE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; IN VITRO STUDY; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; VALERIANA OFFICINALIS;

RATTUS; VALERIANA; VALERIANA OFFICINALIS;

EID: 84984552643     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-009-9917-8     Document Type: Article

References (46)

1. World Health Organization (1992) The ICD-10 classification of mental and behavioral disorders. World Health Organization, Geneva
2. S Ancoli-Israel T Roth 1999 Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey I Sleep 22 S347 S353
3. MJ Sateia K Doghramji PJ Hauri CM Morin 2000 Evaluation of chronic insomnia. An American academy of sleep medicine review Sleep 23 243 308
4. M Ohayon 2002 Epidemiology of insomnia: what we know and what we still need to learn Sleep Med Rev 6 97 111 10.1053/smrv.2002.0186
5. WR Markesbery 1997 Oxidative stress hypothesis in Alzheimer's disease Free Radic Biol Med 23 134 147 10.1016/S0891-5849(96)00629-6
6. D Riemann U Voderholzer 2003 Primary insomnia: a risk factor to develop depression? J Affect Disord 76 255 259 10.1016/S0165-0327(02)00072-1
7. B Halliwell JHC Gutteridge CE Cross 1992 Free radicals, antioxidants and human disease: where we are now? J Lab Clin Med 119 598 620
8. Halliwell B, Gutteridge JMC (eds) (1999) Free radicals in biology and medicine, 3rd edn. Oxford University Press, Oxford, p 936
9. CW Olanow 1993 A radical hypothesis for neurodegeneration Trends Neurosci 16 439 444 10.1016/0166-2236(93)90070-3
10. C Cirelli 2006 Cellular consequences of sleep deprivation in the brain Sleep Med Rev 10 307 321 10.1016/j.smrv.2006.04.001
11. V D'Almeida LL Lobo DC Hipolide AC De Oliveira JN Nobrega S Tufik 1998 Sleep deprivation induces brain region-specific decreases in glutathione levels NeuroReport 9 12 2853 2856 (Pubitemid 28435176)
12. PJ Houghton 1999 The scientific basis for the reputed activity of valerian J Pharmacol 51 505 512 10.1211/0022357991772772
13. A Richman JP Witkowski 1998 4th Annual herbal products sales survey Whole Foods 21 19 26
14. C Gyllenhaal SL Merritt SD Peterson KI Block T Gochenour 2000 Efficacy and safety of herbal stimulants and sedatives in sleep disorders Sleep Med Rev 4 229 251 10.1053/smrv.1999.0093
15. AL Meoli C Rosen D Kristo M Kohrman N Gooneratne RN Aguillard R Fayle R Troell D Touwnsend D Claman T Hoban M Mahowald 2005 Clinical practice review committee of the American academy of sleep medicine. Oral nonprescription treatment for insomnia: an evaluation of products with limited evidence J Clin Sleep Med 2 173 187
16. KT Hallam JS Olver C McGrath TR Norman 2003 Comparative cognitive and psychomotor effects of single doses of Valeriana officinalis and triazolam in healthy volunteers Hum Psychopharmacol 18 619 625 10.1002/hup.542
17. CE Mueller A Brattstrom EA Abourashed U Koetter 2002 Interactions of valerian extracts and a fixed valerian-hop extract combination with adenosine receptors Life Sci 71 1939 1949 10.1016/S0024-3205(02)01964-1
18. BSS Schumacher J Hoelzl N Khudeir S Hess CE Mueller 2002 Lignans isolated from valerian: identification and characterization of a new olive oil derivative with partial agonistic activity at A1 adenosine receptors J Nat Prod 65 1479 1485 10.1021/np010464q
19. 3H]MK-801 binding to rat synaptic membranes Phytother Res 20 9 794 798 10.1002/ptr.1960
20. DM Oliveira G Barreto DEV De Andrade E Saraceno L Aon-Bertolino F Capani RS El Bacha LD Giraldez 2009 Cytoprotective effect of Valeriana officinalis extract on an in vitro experimental model of Parkinson disease Neurochem Res 34 215 220 10.1007/s11064-008-9749-y
21. JO Malva S Santos T Macedo 2004 Neuroprotective properties of Valeriana officinalis extracts Neurotox Res 6 2 131 140
22. H Ohkawa N Ohishi K Yagi 1979 Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal Biochem 95 351 358 10.1016/0003-2697(79) 90738-3
23. RL Puntel CW Nogueira JBT Rocha 2005 N-Methyl-d-aspartate receptors are involved in the quinolinic acid, but not in the malonate pro-oxidative activity in vitro Neurochem Res 30 417 424 10.1007/s11064-005-2617-0
24. B Halliwell JMC Gutteridge OI Aruoma 1987 The deoxyribose method: a simple "Test-tube" assay for determination of rate constants for reactions of hydroxyl radicals Anal Biochem 165 215 219 10.1016/0003-2697(87) 90222-3 (Pubitemid 17131019)
25. JM Monserrat LA Geracitano GLL Pinho TM Vinagre M Faleiros JC Alciati A Bianchini 2003 Determination of lipid peroxides in invertebrates tissues using the Fe(III). Xylenol orange complex formation Arch Environ Contam Toxicol 45 177 183 10.1007/s00244-003-0073-x
26. P Pérez-Severiano M Rodríguez-Pérez J Pedraza-Chaverrí PD Maldonado ON Medina Campos A Ortíz-Plata A Sánchez-García J Villeda-Hernández S Galván-Arzate P Aguilera A Santamaría 2004 S-allylcysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats Neurochem Int 45 1175 1183 10.1016/j.neuint.2004.06.008
27. DJ Kupfer CF Reynolds III 1997 Current concepts: management of insomnia N Engl J Med 336 341 346 10.1056/NEJM199701303360506
28. J Holz P Godau 1989 Receptor binding studies with Valeriana officinalis on the benzodiazepine receptor Planta Med 55 642 10.1055/s-2006-96221
29. R Fachinetto JG Villarinho C Wagner RP Pereira DS Ávila ME Burger JB Calixto JBT Rocha J Ferreira 2007 Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: role of dopamine transporter Prog Neuropsychopharmacol Biol Psychiatry 31 1478 1486 10.1016/j.pnpbp.2007.06.028
30. MO Bostanci F Baǧirici 2008 Neuroprotective effect of aminoguanidine on iron-induced neurotoxicity Brain Res Bull 76 57 62 10.1016/j.brainresbull.2007.11.011
31. G Oboh RL Puntel JBT Rocha 2007 Hot pepper (Capsicum annuum, Tepin and Capsicum chinese, Habanero) prevents Fe2+-induced lipid peroxidation in brain-in vitro Food Chem 102 178 185 10.1016/j.foodchem.2006.05.048
32. Pereira RP, Fachinetto R, Prestes AS, Puntel RL, Silva GNS, Heinzmann BM, Boschetti TK, Athayde ML, Bürger ME, Morel AF, Morsh VM, Rocha JBT (2009) Antioxidant effects of different extracts from Melissa officinalis, Matricaria recutita and Cymbopogon citrates. Neurochem Res (in press). doi: 10.1007/s11064-008-9861-z
33. C Wagner R Fachinetto CL Dalla Corte VB Brito D Severo GOC Dias AF Morel CW Nogueira JBTR Rocha 2006 Quercitrin, a glycoside form of quercetin, prevents lipid peroxidation in vitro Brain Res 1107 192 198 10.1016/j.brainres.2006.05. 084
34. SMK Rates 2001 Plants as source of drugs Toxicon 39 603 613 10.1016/S0041-0101(00)00154-9
35. EA Abourashed U Koetter A Brattstrom 2004 In vitro binding experiments with a valerian, hops, and their fixed combination extract (Ze91019) to selected central nervous system receptors Phytomedicine 11 633 638 10.1016/j.phymed. 2004.03.005
36. E Brouillet P Hantraye RJ Ferrante R Dolan A Leroy-Willig NW Kowall MF Beal 1995 Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates Proc Natl Acad Sci USA 92 7105 7109 10.1073/pnas.92.15.7105
37. I Tǔnez P Montilla MC Muñoz M Feijoo M Salcedo 2004 Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease J Pineal Res 37 252 256 10.1111/j.1600-079X.2004.00163.x
38. JN Bates MT Baker R Guerra DG Harrison 1990 Nitric oxide generation from nitroprusside by vascular tissue Biochem Pharmacol 42 157 165 10.1016/0006-2952(91)90406-U
39. J Chen B Chang M Williams F Murad 1991 Sodium nitroprusside degenerates cultured rat striatal neurons NeuroReport 2 121 123 10.1097/00001756-199103000- 00002
40. RE Loiacono PM Beart 1992 Hippocampal-lesions induced by microinjection of the nitric-oxide donor nitroprusside Eur J Pharmacol 216 331 333 10.1016/0014-2999(92)90381-D
41. NAV Bellé GD Dalmolin G Fonini MA Rubin JBT Rocha 2004 Polyamines reduces lipid peroxidation induced by different pro-oxidant agents Brain Res 1008 245 251 10.1016/j.brainres.2004.02.036
42. A Santamaría C Ríos 1993 MK-801, an N-Methyl-d-aspartate receptor antagonist, blocks quinolinic acid-induced lipid peroxidation in rat corpus striatum Neurosci Lett 159 51 54 10.1016/0304-3940(93)90796-N (Pubitemid 23283236)
43. K Goda R Kishimoto S Shimizu Y Hamane M Ueda 1996 Quinolinic acid and active oxygens. Possible contribution of active oxygens during cell death in the brain Adv Exp Med Biol 398 247 254 (Pubitemid 126426237)
44. E Graf JR Mahoney RG Bryant JW Eaton 1984 Iron catalyzed hydroxyl radical formation: stringent requirement for free iron coordination site J Biol Chem 259 3620 3624 (Pubitemid 14173396)
45. 2+-induced lipid peroxidation in the initiation of the mitochondrial permeability transition Arch Biochem Biophys 414 255 260 (Pubitemid 36627358)
46. 2+ initiated lipid and protein oxidation Biol Res 33 2 143 150